Basics Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $96.42M Activated in VL: True Average Daily Range Avg Daily Range: $0.90 | 3.43% Avg Daily Range (30 D): $0.05 | 4.00% Avg Daily Range (90 D): $0.06 | 4.00% Institutional Daily Volume Avg Daily Volume: .6M Avg Daily Volume (30 D): .88M Avg Daily Volume (90 D): .79M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 189 Avg Trade Size (Sh.) (90 D): 175 Institutional Trades Total Inst.Trades: 1,910 Avg Inst. Trade: $2.09M Avg Inst. Trade (30 D): $1.92M Avg Inst. Trade (90 D): $1.57M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.75M Avg Closing Trade (30 D): $5.64M Avg Closing Trade (90 D): $2.46M Avg Closing Volume: 120.67K     News Jul 1, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold Jun 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Apr 1, 2025 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Mar 15, 2025 @ 3:25 PM Zentalis Pharmaceuticals Presents Updated Clinical... Source: N/A Mar 3, 2025 @ 10:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.13 $-.67 $-.66 Diluted EPS $-3.13 $-.67 $-.66 Revenue $ 26.87M $ M $ 26.87M Gross Profit $ $ $ Net Income / Loss $ -224.19M $ -48.28M $ -47.47M Operating Income / Loss $ -212.05M $ -45.62M $ -49.85M Cost of Revenue $ $ $ Net Cash Flow $ 4.26M $ 8.03M $ -7.42M PE Ratio